Published in:
01-09-2015 | Original Article
Prediction of different ovarian responses using anti-Müllerian hormone following a long agonist treatment protocol for IVF
Published in: Journal of Endocrinological Investigation | Issue 9/2015
Login to get accessAbstract
Objective
The purpose of this study was to predict the
poor and excessive ovarian response using anti-Müllerian hormone (AMH) levels following a long agonist protocol in IVF candidates.
Research design and methods
Through a prospective cohort study, the type of relationship and appropriate scale for AMH were determined using the fractional polynomial regression. To determine the effect of AMH on the outcomes of ovarian stimulation and different ovarian responses, the multi-nominal and negative binomial regression models were fitted using backward stepwise method. The ovarian response of study subject who entered a standard long-term treatment cycle with GnRH agonist was evaluated using prediction model, separately and in combined models with (ROC) curves.
Results
The use of standard long-term treatments with GnRH agonist led to positive pregnancy test results in 30 % of treated patients. With each unit increase in the log of AMH, the odds ratio of having poor response compared to normal response decreases by 64 % (OR 0.36, 95 % CI 0.19–0.68). Also the results of negative binomial regression model indicated that for one unit increase in the log of AMH blood levels, the odds of releasing an oocyte increased 24 % (OR 1.24, 95 % CI 1.14–1.35). The optimal cut-off points of AMH for predicting excessive and poor ovarian responses were 3.4 and 1.2 ng/ml, respectively, with area under curves of 0.69 (0.60–0.77) and 0.76 (0.66–0.86), respectively.
Conclusion
By considering the age of the patient undergoing infertility treatment as a variable affecting ovulation, use of AMH levels showed to be a good test to discriminate between different ovarian responses.